Martingale Asset Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $759K | Buy |
|
|||||
|
2025
Q1 | $548K | Buy |
|
|||||
|
2024
Q4 | $552K | Buy |
|
|||||
|
2024
Q3 | $439K | Buy |
|
|||||
|
2024
Q2 | $403K | Buy |
|
|||||
|
2024
Q1 | $427K | Sell |
|
|||||
|
2023
Q4 | $547K | Sell |
|
|||||
|
2023
Q3 | $679K | Hold |
|
|||||
|
2023
Q2 | $814K | Buy |
|
|||||
|
2023
Q1 | $833K | Buy |
|
|||||
|
2022
Q4 | $682K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $166K | Buy |
|
|||||
|
2020
Q2 | $206K | Buy |
|